Vendor, Jumet, BEL
Univercells
UEI LGTMMU81N8G3, CAGE BTPN2
1 award and $0 obligated between April 24, 2024 and May 23, 2025, 100% under full and open competition, against 1.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | $0 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75A50123C00070Definitive Contract, April 24, 2024, Full and Open Competition, 1 offers | Barda - Aspr / Daappo / Barda DCMAOffice of Assistant Secretary for Preparedness and Response | Univercells - Aoi #21 Vaccine on Demand: R&D for Mrna Production Reinvented with the Nfinitytm Platform.NAICS 541714, PSC AN13 | $0 |
- Product and service codes
- AN13 Health R&D Services; Health Care Services; Experimental Development
- Transactions
- 3 across 1 awards